在阿尔茨海默病的基于微RNA的最新研究进展
Jaime Ramirez-Gomez1, Sarthak Dalal1, Davin Devara1
1Center of Emphasis in Neuroscience, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.
Journal of Alzheimer's disease : JAD
|February 2, 2025
概括
微RNAs (miRNAs) 显示出作为阿尔茨海默病 (AD) 生物标志物和治疗方法的前景. 特定的miRNAs在AD中异常表达,可能提供诊断潜力,而其他miRNAs则用于认知改善,尽管临床试验面临挑战.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,影响老年人的记忆和身体功能.
- 微RNA (miRNA) 是小的非编码RNA,对于像突触可塑性和亡这样的神经功能至关重要.
- 异常的miRNA表达在阿尔茨海默病患者的各种组织中观察到,这表明它们参与了疾病病理学.
研究的目的:
- 审查微RNAs (miRNAs) 在阿尔茨海默病 (AD) 中的诊断和治疗潜力.
- 为了确定特定的miRNAs作为AD诊断的潜在生物标志物.
- 探索基于miRNA的治疗策略,以改善AD的认知症状.
主要方法:
- 对最近的研究,专利和临床试验数据的分析,这些数据涉及AD中的miRNAs.
- 通过它们与阿尔茨海默氏症特征的相互作用来识别具有诊断潜力的miRNAs,如粉样β和tau.
- 对miRNA模拟物和反感性寡核酸作为AD治疗剂的审查.
主要成果:
- 由于异常表达,一些miRNAs (例如miRNA-29a,miRNA-125b,miRNA-34a) 显示出作为AD生物标志物候选人的希望.
- 特定的miRNAs (例如,miRNA-483-5p,miRNA-124) 正在作为治疗方法进行研究,以恢复内源的miRNA活动并改善认知功能.
- 基于miRNA的AD治疗方法的临床试验面临与实验设计,透明度和参与者数量相关的挑战.
结论:
- miRNAs代表了对新型AD生物标志物和治疗干预措施的重要研究领域.
- 虽然有前途,但基于miRNA的疗法需要进一步开发,以克服临床试验的障碍.
- 目前正在进行的专利活动强调了致力于推进基于miRNA的AD管理策略的承诺.
相关概念视频
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
01:26Alzheimer's Disease: Overview
437
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437
02:30siRNA - Small Interfering RNAs
16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K